DanioLabs Ltd. Appoints Dr. Nigel Blackburn As Head Of Clinical Development
Published: Mar 08, 2006
San Francisco, March 8 (BioSpace) – DanioLabs, a Cambridge, United Kingdom based therapeutics company which focuses on neurology and ophthamology has appointed Dr Nigel Blackburn as Head of Clinical Development.
Nigel joins DanioLabs from Roche.
Contact Suvarna Bhatt at firstname.lastname@example.org.